Induction of apoptosis by ginsenoside Rk1 in SK-MEL-2-human melanoma

被引:33
作者
Kim, Ji Seong [1 ]
Joo, Eun Ji [1 ]
Chun, Jaemoo [1 ]
Ha, Young Wan [2 ]
Lee, Jue-Hee [3 ]
Han, Yongmoon [3 ]
Kim, Yeong Shik [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Inst Nat Prod Res, Seoul 151742, South Korea
[2] Korea Inst Sci & Technol, Bioanal & Biotransformat Res Ctr, Seoul 136791, South Korea
[3] Dongduk Womens Univ, Coll Pharm, Dept ImmunoMicrobiol, Seoul 136714, South Korea
基金
新加坡国家研究基金会;
关键词
Apoptosis; Ginsenoside Rk1; Mutant p53; SK-MEL-2 human melanoma; P53; CANCER; INHIBITION; RG3; ANGIOGENESIS; GROWTH; CELLS;
D O I
10.1007/s12272-012-0416-0
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ginsenosides are active compounds isolated from Panax ginseng Meyer. Among these ginsenosides, less polar ginsenosides such as ginsenoside Rg3 and ginsenoside Rh2 have been demonstrated to have tumor inhibitory effects because of their cytotoxicity. In this study, we evaluated the apoptotic effects of ginsenoside Rk1 in SK-MEL-2 human melanoma. Ginsenoside Rk1 isolated from red ginseng is one of the novel ginsenosides that shows strong cytotoxicity compared to ginsenoside Rg3 in dose- and time-dependent manners. The results of DNA fragmentation, 4',6-diamidino-2-phenylindole staining, and flow cytometric analysis are corroborated that ginsenoside Rk1 induced apoptosis in SK-MEL-2 cells. Western blot analysis revealed up-regulation of Fas, FasL, and Bax protein expression and down-regulation of procaspase-8, procaspase-3, mutant p53 and Bcl-2 protein expression. These findings suggest that ginsenoside Rk1 might be a promising compound to induce apoptosis through both extrinsic and intrinsic pathways in SK-MEL-2 cells.
引用
收藏
页码:717 / 722
页数:6
相关论文
共 17 条
[1]   p53-dependent pathways of apoptosis [J].
Benchimol, S .
CELL DEATH AND DIFFERENTIATION, 2001, 8 (11) :1049-1051
[2]   P53 and the pathogenesis of skin cancer [J].
Benjamin, Cara L. ;
Ananthaswamy, Honnavara N. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 224 (03) :241-248
[3]   Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells [J].
Chen, Junxia ;
Peng, Huimin ;
Xi Ou-Yang ;
He, Xiaoyan .
MELANOMA RESEARCH, 2008, 18 (05) :322-329
[4]   Role of apoptosis in basal cell and squamous cell carcinoma formation [J].
Erb, P ;
Ji, JM ;
Wernli, M ;
Kump, E ;
Glaser, A ;
Büchner, SA .
IMMUNOLOGY LETTERS, 2005, 100 (01) :68-72
[5]   Preparative isolation of four ginsenosides from Korean red ginseng (steam-treated Panax ginseng C. A.!Meyer), by high-speed counter-current chromatography coupled with evaporative light scattering detection [J].
Ha, Young Wan ;
Lim, Soon Sung ;
Ha, In Jin ;
Na, Yun-Cheol ;
Seo, Jung-Ju ;
Shin, Heungsop ;
Son, Sung Ho ;
Kim, Yeong Shik .
JOURNAL OF CHROMATOGRAPHY A, 2007, 1151 (1-2) :37-44
[6]   Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-κB [J].
Kim, Sun Mi ;
Lee, So Yong ;
Cho, Jin Suk ;
Son, Seung Mo ;
Choi, Sang Sook ;
Yun, Yeo Pyo ;
Yoo, Hwan Soo ;
Yoon, Do Young ;
Oh, Ki-Wan ;
Han, Sang Bae ;
Hong, Jin Tae .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 631 (1-3) :1-9
[7]   Anti-tumor activity of the ginsenoside Rk1 in human hepatocellular carcinoma cells through inhibition of telomerase activity and induction of apoptosis [J].
Kim, Young-Joo ;
Kwon, Hak Cheol ;
Ko, Hyeonseok ;
Park, Jeong Hill ;
Kim, Hyun Young ;
Yoo, Ji-Hye ;
Yang, Hyun Ok .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (05) :826-830
[8]   Cellular UV damage responses - Functions of tumor suppressor p53 [J].
Latonen, L ;
Laiho, M .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2005, 1755 (02) :71-89
[9]   Platelet antiaggregating activity of ginsenosides isolated from processed ginseng [J].
Lee, Jin Gyun ;
Lee, Yong Yook ;
Kim, Sun Young ;
Pyo, Jae Sung ;
Yun-Choi, Hye Sook ;
Park, Jeong Hill .
PHARMAZIE, 2009, 64 (09) :602-604
[10]   Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice [J].
Liu, Tai-Guo ;
Huang, Ying ;
Cui, Dan-Dan ;
Huang, Xiao-Bing ;
Mao, Shu-Hua ;
Ji, Ling-Ling ;
Song, Hai-Bo ;
Yi, Cheng .
BMC CANCER, 2009, 9